vimarsana.com

Latest Breaking News On - Joint world health organization - Page 1 : vimarsana.com

Aspartame - is it a possible cause of cancer?

Thomson X Inks Strategic Partnership with Singapore-Based Startup Plano and Set Sights on Managing Myopia in Asia

TX ), a wholly-owned subsidiary of SGX Mainboard-listed Thomson Medical Group Limited (the Group ), today announced a strategic partnership with Plano Pte Ltd ( Plano ), a Singapore-based HealthTech startup. The collaboration will leverage on the respective strengths of TX and Plano to address and manage the rapidly increasing incidence of myopia through innovative technological solutions. Myopia is steadily growing into one of the biggest public health challenges in the world, affecting an estimated 2.6 billion people globally, or about one-third of the world s population. By 2050, myopia is projected to affect 5 billion people, which is estimated to be about half of the world s population

Kubota Vision Provides Update on Kubota Glasses Wearable Device for Myopia Control

Posted on 530 Kubota Vision Inc. (Kubota Vision), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company achieved a milestone by completing a first spectacle-style wearable prototype based on Kubota Glasses technology. (1) Kubota Vision conducted a clinical study in early 2020 with an electronic tabletop optical projection device that embodied Kubota Glasses technology; (2) The company also completed a successful proof-of-concept (POC) clinical study to validate the concept of a wearable myopia-control device based on Kubota Glasses technology in August 2020; (3) Based on these results, the company has completed the first spectacle-style wearable prototype based on Kubota Glasses technology. (Photo: Business Wire)

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.